Apton develops instruments focused on bio-marker identification and qualification, developing tools for autoimmune, inflammatory, blood and lymphatic diseases as well as cancer. Established in 2012, the company is located in Los Altos Hills, California.
CEO & CTO
Bryan Staker is the CEO and CTO of Apton Biosystems. Prior to Apton, Bryan was Director, Hardware Systems at Complete Genomics, Chief Technologist, Glimmerglass Networks and MEMS Device Engineer, Silicon Light Machines. Bryan has his MSEE from BYU and a MS Applied Physics from Stanford.